The Department of Laboratory Medicine and Pathology at the University of Minnesota Medical School is committed to bringing leading-edge basic and applied research and innovation to patient care.

The research-intensive faculty within the department have several major focus areas including cancer, immunology, cardiovascular disease, renal disease, diabetes, and genetics. The faculty consist of tenured associate and full professors, several of which currently hold endowed chairs or professorships. They interface with University of Minnesota departments and centers such as the Center for Immunology, Masonic Cancer Center, and the Institute for Translational Neuroscience.


Pediatric pathologist David Berger joins the LMP faculty

David BergerPediatric pathologist David Berger joined our department in July as an assistant professor in our division of Anatomic Pathology.  He comes to the University from Texas Children’s Hospital where he was a pediatric pathology fellow and Baylor College of Medicine where he completed his residency in AP/CP pathology.    Berger joins Mark Luquette as staff pathologists at the Masonic Children’s Hospital.  Berger’s clinical research interests include myelofibrosis and myeloid cancers in children and young adults.  Contact  Dr. Berger at:  273-4014 (office), 899-6114 (pager), e-mail:

Biopreservation short course

Learn best practices for preservation of cells used therapeutically

David McKenna and Allison Hubel and their colleagues in the University’s Biopreservation Core Resource will host the short course “Preservation of Cellular Therapies” Sept. 27-28.  The course is designed for managers of cell therapy laboratories, technicians who preserve cells as a part of their daily routine, scientists involved in the development of cell therapies, companies that produce products for the cell therapy space, and repositories that store cells to be used therapeutically. Lecture topics include:

  • Fundamentals of cryopreservation
  • Protocol development
  • Regulatory issues in cryopreservation
  • Designing a storage facility
  • Containers, reagents and equipment
  • Emerging issues in preservation of cell therapies
  • Clinical cell cryopreservation
  • Quality control

Online registration for "Preservation of Cellular Therapies"

Research spotlight

Skubitz awarded DOD grant for ovarian cancer detection research

Amy Skubitz

The U.S. Department of Defense awarded Amy Skubitz a two-year grant, effective August 1,  to study a revolutionary method for detecting ovarian cancer, the fifth-leading cause of cancer deaths in women in the U.S.  The funding will enable Skubitz’s laboratory to screen Pap test specimens using mass spectrometry (MS) with the working hypothesis that proteins shed by ovarian cancer cells can be detected in the Pap test fixative by MS-based proteomics and thus can serve as cancer biomarkers.  Skubitz’s long-term goal is to develop a noninvasive screening test that can be incorporated into a routine Pap test or a self-administered home test to screen simultaneously for cervical and ovarian cancer.  The project brings together experts in gynecologic oncology, mass spectrometry, bioinformatics, cancer biology, pathology, and statistics.